A Gas Chromatography – Ion Mobility Spectrometry dataset for colorectal cancer diagnostic of 56 urine samples corresponding to 29 subjects. (Q9971)

From MaRDI portal
Dataset published at Zenodo repository.
Language Label Description Also known as
English
A Gas Chromatography – Ion Mobility Spectrometry dataset for colorectal cancer diagnostic of 56 urine samples corresponding to 29 subjects.
Dataset published at Zenodo repository.

    Statements

    0 references
    Contents of the dataset The dataset includes the set of urine samples in .mea format, which can be read using the GCIMS R package. It also contains analytical standards in the same format, used for quality control of the equipment and as a retention time alignment reference. If you want to preview the data, you do not need to download the full Urines.zip and AnalyticalStandards.zip files, but rather use the smaller UrinesDemo.zip and AnalyticalStandardsDemo.zip, with a subset of just three samples of the whole dataset. Besides the actual measurements, you will find the annotations.csv and reference_peaks.csv files, with sample annotations and some reference peaks identified in the samples. See further details below. Sample collection Urine samples from 29 subjects were collected at Hospital de Reus. 15 subjects were diagnosed with colorectal cancer, 14 subjects were controls. The study protocol was approved by the Ethics Committee of Hospital de Reus (study approval no. 074/2018). Samples were aliquoted and frozen at -80C for storage. Sample preparation Sample preparation improves urine preservation by blocking bacterial growth in the urine, and favours volatile extraction. It also adds an internal standard for verification of instrument variability. Stock solution preparation Dissolve 11.69 g of NaCl in about 35 mL deionized water and add 6.5 mg sodium azide (NaN3). Once dissolved, add 5.50 mL 5M HCl and mark up to volume with deionized water until the final volume is 50mL. The HCl 5M is used to obtain an acid pH. The pH is controlled with a pH test paper. The final pH level must be 2 or below. The NaCl favors the volatile extraction, and the NaN3 omits the bacterial growth in the urine. Internal standard solution preparation The 4-flurobenzaldehyde is located in retention time around 200 seconds and can be used as an internal standard. Prepare a methanol stock solution using 100 ml of methanol grade for preparative chromatography and 200 ml of distilled water. Mix 5 mL of 4-fluorobenzaldehyde with 100 mL of the methanol stock solution. Dilute the previous mixture in 400 mL of mili-Q water. Sample preparation Aliquotes were thawed before analysis. Once thawed, 300uL of the stock solution were added to the urine sample, and 1.5 ml of the acidified urine sample were transferred into a 20ml vial, ensuring only the supernatant of the sample is transferred. Finally, 20 mL of the internal standard solution is added to the sample. GC-IMS Analysis Samples were analyzed with a GC-IMS FlavourSpec instrument from G.A.S. Dortmund (Dortmund, Germany). Samples were incubated for 15 minutes at 60C, the flow rate of the drift gas was set at 200 ml/min, and the carrier gas was set 11 ml/min. Both the drift and carrier gas were Nitrogen 5.0. The GC and IMS temperature were set at 60C and the measurement time lasted 33 minutes. Besides the urines, a set of measurements of a ketone mixture was also analyzed at least once per day as an analytical standard control of the equipment. The mixture included 6 ketones (2-butanone, 2-pentanone, 2-hexanone, 2-heptanone, 2-ocatanone and 2-nonanone). This mixture is measured in the same conditions as the urine samples. Samples are provided in the native instrument format (.mea format), that can be read with the GCIMS R package or with the instrument software. Sample annotations The dataset includes a CSV file with sample annotations. The annotations include the following information: Diagnostic: Either ColorectalCancer or Control Sex: Either Male or Female Sample volume (in ml) Fasting: Whether the sample was collected with the patient in fasting conditions Age in years Weight_kg Height_cm BMI Smoker: TRUE/FALSE, whether the patient smoked Diseases: Whether the patient suffered from ArterialHypertension, CardiacFailure, Cholesterol, Dyslipidemia, Fibromyalgia or Tuberculosis AnalysisDateTime: Date and time of the GC-IMS analysis of the sample Reference peaks Some peaks were manually annotated to ease the alignment of the samples and explore alignment solutions. While manual peak labelling is not generally required, we attach those reference peaks as well and their locations, in case they are of interest. These reference peaks are found at reference_peaks.csv.
    0 references
    16 May 2023
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    v.2
    0 references

    Identifiers

    0 references